Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
- 29 August 2001
- Vol. 19 (32) , 4652-4660
- https://doi.org/10.1016/s0264-410x(01)00233-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding MotifJournal of Virology, 2001
- An algorithm for the prediction of proteasomal cleavagesJournal of Molecular Biology, 2000
- Characterization of an in situ IFN-γ ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunizationJournal of Immunological Methods, 2000
- The specificity of proteasomes: impact on MHC class I processing and presentation of antigensImmunological Reviews, 1999
- T lymphocyte responses in HIV-1 infection: implications for vaccine developmentCurrent Opinion in Immunology, 1999
- Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genomeInternational Immunology, 1996
- Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.Proceedings of the National Academy of Sciences, 1995
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope.The Journal of Experimental Medicine, 1992
- Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.The Journal of Experimental Medicine, 1991